Aug 2 (Reuters) - British engineering firm Smiths Group said on Monday it will sell its medical unit for $2.3 billion including debt to a subsidiary of funds advised by U.S. private equity firm TA Associates, and planned to make shareholder returns following the sale. (Reporting by Yadarisa Shabong in Bengaluru; Editing by Shinjini Ganguli)
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,598 GBX | -0.59% | +0.50% | -9.38% |
Apr. 15 | Envista Holdings Names Paul Keel as CEO | MT |
Apr. 11 | Dwindling US Fed cut hope unnerves markets | AN |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.38% | 6.9B | |
+12.22% | 878B | |
+0.03% | 239B | |
+25.05% | 174B | |
-8.58% | 127B | |
+30.14% | 81.93B | |
-5.51% | 75.21B | |
-16.89% | 50.92B | |
-24.36% | 39.43B | |
+19.91% | 33.5B |
- Stock Market
- Equities
- SMIN Stock
- News Smiths Group plc
- Smiths : to sell medical division for $2.3 bln including debt